Evaluation of the Possible Relationship Between Preeclampsia and Periodontal Disease
NCT ID: NCT03603236
Last Updated: 2018-07-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2018-02-17
2018-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary objective of the study is to analyze the relationship between preeclampsia and periodontal infection, using clinical, biochemical and microbiological methods.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Possible Relationship Between Periodontal Disease and Preterm Labor
NCT03610841
Maternal Periodontal Status and Cytokines in Preeclampsia
NCT03088228
Metabolic Profiling of Saliva in Pregnancy and Periodontal Disease
NCT07054177
Stress and Gingival Inflammation in Non-pregnant and Pregnant Women
NCT03336957
Periodontal Status and Pregnancy or Delivery Complications in Type 1 Diabetes Mellitus Pregnant Women
NCT06002997
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Periodontal disease is a subclinical and persistent infection source which induces the systemic inflammatory reactions and increases the risk of preeclampsia. It is believed that the results will set light to the etiology of preeclampsia and will help to develop strategies to prevent the disease.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
preeclampsia
18-40 aged diagnosed with preeclampsia
preeclampsia
liver function tests, kidney function tests and platelets measures the ratio of protein to creatinine
control
liver function tests, kidney function tests and platelets measures the ratio of protein to creatinine
control
18- 40 aged healthy females over 37. weeks of pregnant with no history of preeclampsia
preeclampsia
liver function tests, kidney function tests and platelets measures the ratio of protein to creatinine
control
liver function tests, kidney function tests and platelets measures the ratio of protein to creatinine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
preeclampsia
liver function tests, kidney function tests and platelets measures the ratio of protein to creatinine
control
liver function tests, kidney function tests and platelets measures the ratio of protein to creatinine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 37\. weeks of pregnant women with no history of preterm labor
Exclusion Criteria
* pregnancy or pre-pregnancy hypertension,
* HIV infection,
* diabetes mellitus,
* multiple pregnancy, preterm labor / low birth weight,
* smoker and alcohol use history,
* IVF pregnancy,
* placental, cervical and uterine anomalies,
* pregnancy with intrauterine growth retardation,
* pregnancies with congenital or chromosomal fetal anomalies,
* significant vaginal bleeding,
* infertility stories,
* drug addicts,
* poor socioeconomic level
21 Years
34 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ege University
OTHER
Recep Tayyip Erdogan University Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gul Yildiz Telatar
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gül Yıldız Telatar
Role: PRINCIPAL_INVESTIGATOR
Recep Tayyip Erdogan University Dentistry Faculty
Önder Gürlek, Dr.
Role: PRINCIPAL_INVESTIGATOR
Ege University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ege University Dentistry Faculty
Izmir, , Turkey (Türkiye)
İzmir Health Sciences University, Tepecik Training and Research Hospital Department of Obstetrics and Gynecology
Izmir, , Turkey (Türkiye)
Recep Tayyip Erdogan University Dentistry Faculty
Rize, , Turkey (Türkiye)
Recep Tayyip Erdogan University Faculty of Medicine
Rize, , Turkey (Türkiye)
Glaskow Dental School , School of Medicine University of Glasgow
Glaskow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Jaiman G, Nayak PA, Sharma S, Nagpal K. Maternal periodontal disease and preeclampsia in Jaipur population. J Indian Soc Periodontol. 2018 Jan-Feb;22(1):50-54. doi: 10.4103/jisp.jisp_363_15.
Related Links
Access external resources that provide additional context or updates about the study.
Maternal periodontal disease and preeclampsia in Jaipur population.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
40465587-28
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.